Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Aeglea Biothera (AGLE)

Aeglea Biothera (AGLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Aeglea: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Aeglea: Q3 Earnings Snapshot

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Grants of Inducement Awards PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics to Participate in Upcoming September Conference PR Newswire - Thu Sep 14, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Reverse Stock Split PR Newswire - Thu Sep 7, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
ARQT : 8.78 (+1.27%)
Aeglea: Q2 Earnings Snapshot AP - Fri Aug 11, 2023

Aeglea: Q2 Earnings Snapshot

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results PR Newswire - Fri Aug 11, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma PR Newswire - Thu Jul 27, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with best-in-class...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Grant of Inducement Awards PR Newswire - Fri Jun 23, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE) today announced that, in connection with the acquisition of Spyre Therapeutics, Inc....

AGLE : 12.01 (+8.79%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs FinancialNewsMedia - Thu Jun 22, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END

ONCY : 1.1600 (-1.69%)
ONC.TO : 1.61 (-3.01%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 0.6705 (-2.85%)
MRTX : 58.70 (-0.17%)

Barchart Exclusives

Is Amazon Stock a Buy? Here’s What Investors Need to Know Now Barchart - 1 hour ago
Amazon is doubling down on key growth areas that could drive further stock gains in the future. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot